Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 1345-1353

  Ball, Judith M ^a,b   Hardy, Michele E ^a   Atmar, Robert L ^a   Conner, Margaret E ^a   Estes, Mary K ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; GASTROENTERITIS; MOUSE; NONHUMAN; NORWALK GASTROENTERITIS VIRUS; PRIORITY JOURNAL; VIRION; VIRUS GENE; VIRUS PARTICLE; VIRUS RECOMBINANT;

EID: 0031906229     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.1345-1353.1998     Document Type: Article

References (59)

1. Bergmann, K.-C., and R. H. Waldman. 1988. Stimulation of secretory antibody following oral administration of antigen. Rev. Infect. Dis. 10:939-950.
2. Challacombe, S. J. 1987. Cellular factor in the induction of mucosal immunity by oral immunization. Adv. Exp. Med. Biol. 216b:887-899.
3. Coffman, R. L., D. A. Lebman, and B. Shrader. 1989. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med. 170:1039-1044.
4. Coutelier, J.-P., J. T. M. van der Logt, F. W. A. Heessen, A. Vink, and J. van Snick. 1988. Virally induced modulation of murine IgG antibody subclasses. J. Exp. Med. 168:2373-2378.
5. Coutelier, J.-P., J. T. M. van der Logt, F. W. A. Heessen, G. Warnier, and J. van Snick. 1987. IgG2a restriction of murine antibodies elicited by viral infections. J. Exp. Med. 165:64-69.
6. Coutelier, J.-P., E. van Roost, P. Lambotte, and J. van Snick. 1986. The murine antibody response to lactate dehydrogenase-elevating virus. J. Gen. Virol. 67:1099-1108.
7. Cukor, G., and N. R. Blacklow. 1984. Human viral gastroenteritis. Microbiol. Rev. 48:157-179.
8. de Becker, G., T. Sornasse, N. Nabavi, H. Bazin, F. Tielemans, J. Urbain, O. Leo, and M. Moser. 1994. Immunoglobulin isotypc regulation by antigen-presenting cells in vivo. Eur. J. Immunol. 24:1523-1528.
9. Dimitrov, D. H., S. A. H. Dashti, J. M. Ball, E. Bishbishi, K. Alsaeid, X. Jiang, and M. K. Estes. 1997. Prevalence of antibodies to human caliciviruses (HuCVs) in Kuwait established by ELISA using baculovirus-expressed capsid antigens representing two genogroups of HuCVs. J. Med. Virol. 51:115-118.
10. Eldridge, J. H., R. M. Gilley, J. K. Staas, Z. Moldoveanu, J. A. Meulbroek, and T. R. Tice. 1989. Biodegradable microspheres: vaccine delivery system for oral immunization. Curr. Top. Microbiol. Immunol. 146:59-66.
11. Estes, M. K., R. L. Atmar, and M. E. Hardy. 1997. Norwalk and related diarrhea viruses, p. 1073-1095. In D. D. Richman, R. J. Whitley, and F. G. Hayden (ed.), Clinical virology. Churchill Livinstone, New York, N.Y.
12. Estrada, A., M. R. McDermott, B. J. Underdown, and D. P. Snider. 1995. Intestinal immunization of mice with antigen conjugated to anti-MHC class II antibodies. Vaccine 13:901-907.
13. Farag-Mahmod, F. I., P. R. Wyde, J. P. Rosborough, and H. R. Six. 1988. Immunogenicity and efficacy of orally administered inactivated influenza virus vaccine in mice. Vaccine 6:262-268.
14. Filgueira, D. M. P., A. Berinstein, E. Smitsaart, M. V. Borca, and A. M. Sadir. 1995. Isotype profiles induced in Balb/c mice during foot and mouth disease (FMD) virus infection or immunization with different FMD vaccine formulations. Vaccine 13:953-960.
15. Graham, D. Y., X. Jiang, T. Tanaka, A. R. Opekun, H. P. Madore, and M. K. Estes. 1994. Norwalk virus infection of volunteers: new insights based on improved assays. J. Infect. Dis. 170:34-43.
16. Green, K. Y., J. F. Lew, X. Jiang, A. Z. Kapikian, and M. K. Estes. 1993. Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J. Clin. Microbiol. 31:2185-2191.
17. Greenberg, H. B., J. R. Valdesuso, A. R. Kalica, R. G. Wyatt, V. J. McAuliffe, A. Z. Kapikian, and R. M. Chanock. 1981. Proteins of Norwalk virus. J. Virol. 37:994-999.
18. Hanson, D. G. 1981. Ontogeny of orally induced tolerance to soluble proteins in mice. I. Priming and tolerance in newborns. J. Immunol. 127:1518-1522.
19. Hanson, D. G., and S. D. Miller. 1982. Inhibition of specific immune responses by feeding protein antigens. V. Induction of the tolerant state in the absence of specific suppressor T cells. J. Immunol. 128:2378-2381.
20. Hardy, M. E., T. N. Tanaka, N. Kitamoto, L. J. White, J. M. Ball, X. Jiang, and M. K. Estes. 1996. Antigenic mapping of the recombinant Norwalk virus capsid protein using monoclonal antibodies. Virology 217:252-261.
21. Hardy, M. E., L. J. White, J. M. Ball, and M. K. Estes. 1995. Specific proteolytic cleavage of recombinant Norwalk virus capsid protein. J. Virol. 69:1693-1698.
22. Hedberg, C. W., and M. T. Osterholm. 1993. Outbreaks of food-borne and waterborne viral gastroenteritis. Clin. Microbiol. Rev. 6:199-210.
23. Holmgren, J., C. Czerkinsky, N. Lycke, and A.-M. Svennerholm. 1992. Mucosal immunity: implications for vaccine development. Immunobiology 184: 157-179.
24. Jiang, X., D. Y. Graham, K. N. Wang, and M. K. Estes. 1990. Norwalk virus genome cloning and characterization. Science 250:1580-1583.
25. Jiang, X., D. O. Matson, F. R. Velazquez, W. Zhong, J. Hu, G. Ruiz-Palacios, and L. K. Pickering. 1995. A study of Norwalk related viruses in Mexican children. J. Med. Virol. 47:309-316.
26. Jiang, X., M. Wang, D. Y. Graham, and M. K. Estes. 1992. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 66:6527-6532.
27. Jiang, X., M. Wang, K. Wang, and M. K. Estes. 1993. Sequence and genomic organization of Norwalk virus. Virology 195:51-61.
28. Kapikian, A. Z., M. K. Estes, and R. M. Chanock. 1996. Norwalk group of viruses, p. 783-810. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology. Raven Press, New York, N.Y.
29. Kaplan, J. E., G. W. Gary, R. C. Baron, N. Singh, L. B. Schonberger, R. Feldman, and H. B. Greenberg. 1982. Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann. Intern. Med. 96:756-761.
30. Khoury, C. A., C. A. Moser, T. J. Speaker, and P. A. Offit. 1995. Oral inoculation of mice with low doses of microencapsulated, noninfectious rotavirus induces virus-specific antibodies in gut-associated lymphoid tissue. J. Infect. Dis. 172:870-874.
31. Kipps, T. J., P. Parham, J. Punt, and L. A. Herzemberg. 1985. Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J. Exp. Med. 161:1-17.
32. Klaus, G. G. B., M. B. Pepys, K. Kitajina, and B. A. Asconas. 1979. Activation of mouse complement by different classes of mouse antibody. J. Immunol. 38:687-695.
33. Klipstein, F. A., R. F. Engert, and W. T. Sherman. 1983. Peroral immunization of rats with Escherichia coli heat-labile enterotoxin delivered by microspheres. Infect. Immun. 39:1000-1003.
34. Labbe, M., A. Charpilienne, S. E. Crawford, M. K. Estes, and J. Cohen. 1991. Expression of rotavirus VP2 produces empty corelike particles. J. Virol. 65:2946-2952.
35. Levin, J., and F. B. Bang. 1968. Clottable protein in Limulus: its localization and kinetics of its coagulation by endotoxin. Thromb. Diath. Haemorrh. 19:186-197.
36. Marinaro, M., H. F. Staats, T. Hiroi, R. J. Jackson, M. Coste, P. N. Boyaka, N. Okahashi, M. Yamamoto, H. Kiyono, H. Bluethmann, K. Fujihashi, and J. R. McGhee. 1995. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 155:4621-4629.
37. Mattingly, J. A., and B. H. Waksman. 1980. Immunologic suppression after oral administration of antigen. II. Antigen specific helper and suppressor factors produced by spleen cells of rats fed sheep erythrocytes. J. Immunol. 125:1044-1047.
38. McGhee, J. R., J. Mestecky, C. O. Elson, and H. Kiyono. 1989. Regulation of IgA synthesis and immune response by T cells and interleukins. J. Clin. Immunol. 9:175-199.
39. McIntyre, T. M., D. R. Klinman, P. Rothman, M. Lugo, J. R. Dasch, J. J. Mond, and C. M. Snapper. 1993. Transforming growth factor beta-1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells. J. Exp. Med. 177:1031-1037.
40. Mestecky, J. 1987. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 7:265-276.
41. Mestecky, J., and J. R. McGhee. 1987. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response, p. 153-245. In Anonymous advances in immunology. Academic Press, Inc., New York, N.Y.
42. Mestecky, J., and J. R. McGhee. 1992. Prospects for human mucosal vaceines, p. 13-23. In J. E. Ciardi et. al. (ed.), Genetically engineered vaccines. Plenum Press, New York, N.Y.
43. Moldoveanu, A., M. Novak, W. Huang, R. M. Gilley, J. K. Staas, D. Schafer, R. W. Compans, and J. Mestecky. 1993. Oral immunization with influenza virus in biodegradable microspheres. J. Infect. Dis. 167:84-90.
44. Novitsky, T. J. 1984. Discovery to commercialization: the blood of the horseshoe crab. Oceanus 27:13-18.
45. Ogra, P. L. 1984. Mucosal immune response to poliovirus vaccines in childhood Rev. Infect. Dis. 6:S361-S368.
46. Ogra, P. L., and D. T. Karzon. 1969. Distribution of poliovirus antibody in serum, nasopharynx, and alimentary tract following segmental immunization of lower alimentary tract with polio vaccine. J. Immunol. 102:1423-1430.
47. Ogra, P. L., D. T. Karzon, F. Righthand, and M. MacGillivray. 1968. Immunoglobulin response in serum and secretions after immunization with live and inactivated polio vaccine and natural infection. N. Engl. J. Med. 279: 893-900.
48. O'Hagan, D. T., H. Jeffery, M. J. J. Roberts, J. P. McGee, and S. S. Davis. 1991. Controlled release microparticles for vaccine development. Vaccine 9:768-771.
49. Prasad, B. V. V., R. Rothnagel, X. Jiang, and M. K. Estes. 1994. Three-dimensional structure of baculovims-expressed Norwalk virus capsids. J. Virol. 68:5117-5125.
50. Schwab, K. J., M. K. Estes, F. H. Neill, and R. L. Atmar. 1997. Use of heat release and an internal RNA standard control in reverse transcription-PCR detection of Norwalk virus from stool samples. J. Clin. Microbiol. 35:511-514.
51. Sharp, T. W., K. C. Hyams, D. Watts, A. F. Trofa, G. J. Martin, A. Z. Kapikian, K. Y. Green, X. Jiang, M. K. Estes, M. Waack, et al. 1995. Epidemiology of Norwalk virus during an outbreak of acute gastroenteritis aboard a U.S. aircraft carrier. J. Med. Virol. 45:61-67.
52. Snapper, C. M., W. Waegell, H. Beernink, and J. R. Dasch. 1993. Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro. J. Immunol. 151:4626-4636.
53. Sosroseno, W. 1995. A review of the mechanisms of oral tolerance and immunotherapy. J. R. Soc. Med. 88:14-17.
54. Summers, M. D., and G. E. Smith. 1987. A manual of methods for baculovirus vectors and insect cell culture procedures, bulletin no. 1555. Texas Agricultural Experiment Station, College Station, Tex.
55. Thomsen, A. R., M. Volkert, and O. Marker. 1985. Different isotype profiles of virus-specific antibodies in acute and persistent lymphocytic choriomeningitis virus infection in mice. Immunology 55:213-223.
56. van Ginkel, F. W., C. Liu, J. W. Simecka, J.-Y. Dong, T. Greenway, R. A. Frizzell, H. Kiyono, J. R. McGhee, and D. W. Pascual. 1995. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and beta-galactosidase. Hum. Gene Ther. 6:895-903.
57. Vinje, J., S. A. Altena, and M. P. G. Koopmans. 1997. The incidence and genetic variability of small round structured viruses in outbreaks of gastroenteritis in The Netherlands. J. Infect. Dis. 176:1374-1378.
58. Wachsmann, D., J. P. Klein, M. Scholler, and R. M. Frank. 1985. Local and systemic immune responses to orally administered liposome-associated soluble S. mutans cell wall antigens. Immunology 54:189-193.
59. White, L. J., J. M. Ball, M. E. Hardy, T. N. Tanaka, N. Kitamoto, and M. K. Estes. 1996. Attachment and entry of recombinant Norwalk virus capsids to cultured human and animal cell lines. J. Virol. 70:6589-6597.